Form 4: Elanco Animal Health CEO Acquires Deferred Stock Units

Elanco Animal Health CEO Jeffrey N. Simmons acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Summary

• On March 8, 2024, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired 168.3429 deferred stock units.
• These deferred stock units represent the right to receive one share of Elanco common stock or the cash equivalent.
• The price of the deferred stock units was $16.45.
• Following the transaction, Simmons directly owns 871.4241 deferred stock units.
• The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of deferred stock units can be seen as a slightly positive sign, indicating confidence, but it's not a major event.

Positives

• The CEO's acquisition of deferred stock units could be interpreted as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation through deferred stock units is a common practice in publicly traded companies to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Deferred stock units are a common component of executive compensation packages in the animal health and pharmaceutical industries.
• Companies like Zoetis and Merck Animal Health also utilize similar equity-based compensation plans to incentivize their executives.
• The specific terms and conditions of these plans, such as vesting schedules and settlement options, can vary significantly between companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the CEO's interests with the company's long-term performance.

Key Dates